666 related articles for article (PubMed ID: 34932874)
21. Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: Real-life data from Denmark.
Hamm SR; Rezahosseini O; Møller DL; Loft JA; Poulsen JR; Knudsen JD; Pedersen MS; Schønning K; Harboe ZB; Rasmussen A; Sørensen SS; Nielsen SD
Am J Transplant; 2022 Nov; 22(11):2637-2650. PubMed ID: 35801693
[TBL] [Abstract][Full Text] [Related]
22. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort.
Giannella M; Huth M; Righi E; Hasenauer J; Marconi L; Konnova A; Gupta A; Hotterbeekx A; Berkell M; Palacios-Baena ZR; Morelli MC; Tamè M; Busutti M; Potena L; Salvaterra E; ; Feltrin G; Gerosa G; Furian L; Burra P; Piano S; Cillo U; Cananzi M; Loy M; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Baño JR; Lazzarotto T; Viale P; Tacconelli E
Clin Microbiol Infect; 2023 Aug; 29(8):1084.e1-1084.e7. PubMed ID: 37150358
[TBL] [Abstract][Full Text] [Related]
23. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
[TBL] [Abstract][Full Text] [Related]
24. Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19.
Jabr R; Khatri A; Anderson AD; Garcia LC; Viotti JB; Natori Y; Raja M; Camargo JF; Morris MI
Transpl Infect Dis; 2023 Feb; 25(1):e14006. PubMed ID: 36704987
[TBL] [Abstract][Full Text] [Related]
25. A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.
Ahearn AJ; Thin Maw T; Mehta R; Emamaullee J; Kim J; Blodget E; Kahn J; Sher L; Genyk Y
Transplantation; 2022 Feb; 106(2):e153-e157. PubMed ID: 34519680
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.
Wang AX; Busque S; Kuo J; Singh U; Röeltgen K; Pinsky BA; Chertow GM; Scandling JD; Lenihan CR
Kidney360; 2022 Jan; 3(1):133-143. PubMed ID: 35368573
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
[TBL] [Abstract][Full Text] [Related]
28. An overview of COVID-19 in solid organ transplantation.
Bartelt L; van Duin D
Clin Microbiol Infect; 2022 Jun; 28(6):779-784. PubMed ID: 35189336
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.
Burack D; Pereira MR; Tsapepas DS; Harren P; Farr MA; Arcasoy S; Cohen DJ; Mohan S; Emond JC; Hod EA; Verna EC
Am J Transplant; 2021 Jun; 21(6):2254-2261. PubMed ID: 33590675
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and solid organ transplantation: Finding the right balance.
Opsomer R; Kuypers D
Transplant Rev (Orlando); 2022 Jul; 36(3):100710. PubMed ID: 35809422
[TBL] [Abstract][Full Text] [Related]
32. Excess mortality in solid organ transplant recipients hospitalized with COVID-19: A large-scale comparison of SOT recipients hospitalized with or without COVID-19.
Jering KS; McGrath MM; Mc Causland FR; Claggett B; Cunningham JW; Solomon SD
Clin Transplant; 2022 Jan; 36(1):e14492. PubMed ID: 34558116
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of Severe SARS-CoV-2 Infection in Fully Vaccinated Solid Organ Transplant Recipients.
Marinaki S; Xagas E; Tsoutsoura P; Katsaros D; Korogiannou M; Boletis IN
Transplant Proc; 2022; 54(6):1405-1408. PubMed ID: 35074163
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know.
Giannella M; Pierrotti LC; Helanterä I; Manuel O
Transpl Int; 2021 Oct; 34(10):1776-1788. PubMed ID: 34450686
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.
Roberts MB; Izzy S; Tahir Z; Al Jarrah A; Fishman JA; El Khoury J
Transpl Infect Dis; 2020 Oct; 22(5):e13407. PubMed ID: 32654303
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
[TBL] [Abstract][Full Text] [Related]
37. Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients.
Jordan SC; Joung SY; Wang M; Tran TA; Bravo M; Masoom H; Chang C; Mendez M; Sun N; Patel J; Kittleson M; Frias E; Prostko JC; Ebinger JE; Cheng S; Sobhani K
Transpl Infect Dis; 2024 Feb; 26(1):e14182. PubMed ID: 37885435
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
[TBL] [Abstract][Full Text] [Related]
39. Initial experience of bamlanivimab monotherapy use in solid organ transplant recipients.
Kutzler HL; Kuzaro HA; Serrano OK; Feingold A; Morgan G; Cheema F
Transpl Infect Dis; 2021 Oct; 23(5):e13662. PubMed ID: 34081820
[TBL] [Abstract][Full Text] [Related]
40. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
